Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Beam Therapeutics Inc.(BEAM) | 2,346,934 | 2,346,934 | 0 | $56.44M | $63.88M | 53.74% | +$7.44M |
| Lyell Immunopharma, Inc.(LYEL) | 20,162,332 | 20,162,332 | 0 | $29.64M | $39.11M | 32.90% | +$9.48M |
| Prime Medicine, Inc.(PRME) | 1,792,210 | 1,792,210 | 0 | $17.10M | $15.88M | 13.36% | -$1.22M |